| Ms Jennifer Dawn Griffin, MS, CF-SLP | |
|
17706 I-30 Ste 3, Benton, AR 72019-2930 | |
| (501) 315-4414 | |
| (501) 315-3467 |
| Full Name | Ms Jennifer Dawn Griffin |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 17706 I-30 Ste 3, Benton, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437331022 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SP#P8080 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Jennifer Dawn Griffin, MS, CF-SLP 17706 I-30 Ste 3, Benton, AR 72019-2930 Ph: (501) 315-4414 | Ms Jennifer Dawn Griffin, MS, CF-SLP 17706 I-30 Ste 3, Benton, AR 72019-2930 Ph: (501) 315-4414 |
News Archive
New approaches and tools are needed to improve visual accessibility for people with low vision in the "real world," according to a special article in the July issue of , official journal of the the American Academy of Optometry.
Vermillion, a molecular diagnostics company, today announced that it has signed an agreement with Quest Diagnostics to make OVA1 available in India. The companies are targeting a launch in the second quarter of 2011. Additionally, at the International Gynecologic Cancer Society (IGCS) regional meeting held in New Delhi April 2-3, 2011, Dr. Fred Ueland presented data demonstrating the high sensitivity for ovarian malignancy of OVA1 in combination with ultrasound.
Biogen Idec and Elan Corporation, plc today announced data has been published in the Annals of Neurology on an investigational, two-step assay to detect anti-JC virus (JCV) antibodies in human serum and plasma
A new clinical guideline from the American Society for Radiation Oncology provides recommendations on the use of radiation therapy to treat patients diagnosed with pancreatic cancer, including when radiation treatments are appropriate, as well as the optimal dosing, timing and fractionation for these treatments.
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced a new Multispecies Imaging Module for PerkinElmer's Fluorescence Molecular Tomography In Vivo Imaging Systems.
› Verified 6 days ago
Arkansas Therapy Outreach, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3851 Legacy Village Dr, Benton, AR 72015 Phone: 501-350-7572 Fax: 501-776-4059 | |
Cassandra Powell, M.S.CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Park Dr, Benton, AR 72015 Phone: 501-315-0136 | |
Taylor Gibbs Crosby, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17706 Interstate 30 N Ste 3, Benton, AR 72019 Phone: 501-315-4414 | |
Ryan Russell, MSSLP.CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6701 Highway 67, Benton, AR 72015 Phone: 501-860-0777 | |
Rebekah Anne Kennedy, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17706 Interstate 30 N Ste 3, Benton, AR 72019 Phone: 501-315-4414 | |
Jessica Faye Huffty, MS, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3214 Winchester, Benton, AR 72015 Phone: 501-315-4414 Fax: 501-315-3467 | |
Mckenna Lynn Zeringue, M.S. CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17706 I 30, Benton, AR 72019 Phone: 501-315-4414 |